March 16 | 2024
2CUREX AB (PUBL) PROVIDES AN UPDATE ON ITS FINANCIAL POSITION AND CURRENT OPERATIONS
Read more
December 29 | 2023
2cureX announces changes to the management
Read more
October 26 | 2023
Strategy update: Leapfrogging to the decentralization of IndiTreat® testing through full focus on automation
Read more
May 25 | 2023
2cureX publishes interim report for the first quarter of 2023
Read more
April 25 | 2023
2cureX’s CEO Fernando Andreu purchases shares in the company
Read more
April 12 | 2023
2cureX has received a grant from the Innovation Fund Denmark to support clinical development of a novel IndiTreat® product.
Read more
April 6 | 2023
2cureX strengthens its IndiTreat® automation project with a prestigious grant from the German Federal Ministry of Education and Research
Read more
February 23 | 2023
2cureX publishes interim report for the fourth quarter and full year of 2022
Read more
February 15 | 2023
Invitation to 2cureX webcast on Year-End Report and latest news on February 24, 2023
Read more
January 19 | 2023
2cureX announces final results regarding 2022 goals
Read more
November 24 | 2022
2cureX publishes interim report for the third quarter and first nine months of 2022
Read more
November 14 | 2022
2cureX discloses status of 2022 plans, goals for 2023 and its estimates of potential market development in the coming years
Read more
August 25 | 2022
2cureX offentliggör delårsrapport för det andra kvartalet och första halvåret 2022
Read more
August 25 | 2022
2cureX publishes interim report for the second quarter and first half of 2022
Read more
May 24 | 2022
2cureX publishes interim report for the first quarter 2022
Read more
May 24 | 2022
2cureX offentliggör delårsrapport för det första kvartalet 2022
Read more
May 3 | 2022
2cureX publishes the annual report for the fiscal year 2021
Read more
May 3 | 2022
2cureX offentliggör årsredovisning för räkenskapsåret 2021
Read more